Viemed Healthcare Q4 EPS $0.09 Misses $0.10 Estimate, Sales $50.74M Beat $50.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
Viemed Healthcare (NASDAQ:VMD) reported Q4 earnings of $0.09 per share, missing the consensus estimate of $0.10 by 10%. However, their quarterly sales of $50.74M exceeded the estimate of $50.00M by 1.48%, marking a 35.28% increase from the previous year.

March 06, 2024 | 10:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Viemed Healthcare's Q4 EPS was $0.09, missing estimates by 10%, but sales of $50.74M exceeded expectations, showing significant year-over-year growth.
While the miss on EPS might concern some investors, the beat on revenue and significant year-over-year growth could offset concerns and suggest a positive outlook for the company's growth trajectory. The mixed results make the short-term impact on the stock price uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100